91
Views
9
CrossRef citations to date
0
Altmetric
Review

Surgical management of thyroid cancer

, , , , , & show all
Pages 1203-1214 | Published online: 10 Jan 2014

References

  • Pacini F, Schlumberger M, Dralle H et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol.154, 787–803 (2006).
  • Shaha A. Advances in the management of thyroid cancer. Int. J. Surg.3, 213–220 (2005).
  • Deandrea M, Gallone G, Veglio M et al. Thyroid cancer histotype changes as observed in a major general hospital in a 21-year period. J. Endocrinol. Invest.20, 52–58 (1997).
  • Lind P, Langsteger W, Molnar M et al. Epidemiology of thyroid diseases in iodine sufficiency. Thyroid8, 1179–1183 (1998).
  • Sosa J, Udelsman R. Total thyroidectomy for differentiated thyroid cancer. J. Surg. Oncol.94, 701–707 (2006).
  • I tumori in Italia – Rapporto 2006. Epidemiology e Prevenzione anno 30 gennaio–febbraio supplemento 2 (2006).
  • Timbolli P, Ulisse S, Graziano FM et al. Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid16, 1151–1155 (2006).
  • Abdul-Jabar H, Lynn J. The surgical management of thyroid cancer. Nucl. Med. Commun.25, 869–872 (2004).
  • Chow S, Law S, Au S et al. Cancer incidence and mortality in Hong Kong 1998–1999. Hong Kong Cancer Registry, Hong Kong (2000).
  • Chow SM, Law SC, Au SK et al.Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960–2000. Clin. Oncol.15, 329–336 (2003).
  • Hundahl SA, Fleming ID, Fremgen AM et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US. Cancer83, 2638–2648 (1998).
  • Cady B, Rossi RL. Undifferentiated carcinoma and lymphoma of thyroid gland. In: Surgery of the Thyroid and Parathyroid Glands. Cady B, Rossi RL (Eds). WB Saunders, PA, USA 179–86 (1991)
  • Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann. Surg.228(3), 320–330 (1998).
  • Acun Z, Cihan A, Ulukent SC et al. A randomized prospective study of complications between general surgery residents and attending surgeons in near-total thyroidectomies. Surg. Today34(12), 997–1001 (2004).
  • Manolidis S, Takashima M, Kirby M, Scarlet M. Thyroid surgery: a comparison of outcomes between experts and surgeons in training. Otolaryngol. Head Neck Surg.125(1), 30–33 (2001).
  • Dackiw A, Zeiger M. Extent of surgery for differentiated thyroid cancer. Surg. Clin. N. Am.84, 817–832 (2004).
  • Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery104, 947–953 (1988).
  • Hay ID, Grant CS, Taylor WF et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery102, 1088–1095 (1987).
  • American Joint Committee on Cancer Cancer Staging Manual (6th Edition). Greene FL, Page DL, Fleming IE et al. (Eds). Springer-Verlag, NY, USA 77–87 (2002).
  • Udelsman R, Shaha A. Is total thyroidectomy the best possible surgical management for well-differentiated thyroid cancer? Lancet Oncol.6, 529–531 (2005).
  • Kebebew E, Clark OH. Differentiated thyroid cancer: ‘complete’ rational approach. World J. Surg.24, 942–951 (2000).
  • Dackiw AP, Clark OH. Bilateral thyroidectomy: indications and technique. In: Surgery of the Thyroid and Parathyroid Glands. Randolph GW (Ed.). WB Saunders, PA, USA 284–291 (2003).
  • Jossart GH, Clark OH. Well-differentiated thyroid cancer. Curr. Probl. Surg.31, 933–1012 (1994).
  • Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope114, 393–402 (2004).
  • Shaha AR, Shan JP, Loree TR. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann. Surg. Oncol.4, 328–333 (1997).
  • Dionigi G, Dionigi R, Bartalena L, Boni L, Rovera F, Villa F. Surgery of lymph nodes in papillary thyroid cancer. Expert Rev. Anticancer Ther.6(9), 1217–1229 (2006).
  • Harish K. Thyroglobulin: current status in differentiated thyroid carcinoma (review). Endocr. Reg.40, 53–67 (2006).
  • Dellelis R. Pathology and genetics of thyroid carcinoma. J. Surg. Onc.94, 662–669 (2006).
  • Vasko V, Saji M. Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Curr. Opin. Oncol.19, 11–17 (2007).
  • Arem R, Onativa A, Saliby AH et al. Thyroid microcarcinoma: prevalence, prognosis, and management. Endocr. Pract.5, 148–156 (1999).
  • Baloch Z, LiVolsi A. Microcarcinoma of the thyroid. Adv. Anat. Pathol.13(2), 69–75 (2006).
  • Harach HR, Zampi G, Zusman SB. Occult papillary microcarcinoma of the thyroid – a potential pitfall of fine needle aspiration cytology. J. Clin. Pathol.44, 205–207 (1991).
  • Sampson R, Key C, Bucher C et al. Thyroid carcinoma in Hiroshima and Nagasaki. Prevalance of thyroid carcinoma at autopsy. J. Am. Med. Assoc.209, 65–70 (1969).
  • Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A ‘‘normal’’ finding in Finland. A systematic autopsy study. Cancer56, 531–538 (1985).
  • Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid. Evaluation of 1020 sequential autopsies. Am. J. Clin. Pathol.90, 72–76 (1988).
  • Franssila KO, Harach HR. Occult papillary carcinoma of the hyroid in children and young adults. A systemic autopsy study in Finland. Cancer58, 715–719 (1986).
  • Bondenson L, Ljungberg O. Occult thyroid carcinoma at autopsy in Malmo, Sweden. Cancer47, 319–323 (1981).
  • Sobrinho-Simoes MA, Sambade MC, Goncalves V. Latent thyroid carcinoma at autopsy. A study from Oporto, Portugal. Cancer43, 1702–1706 (1979).
  • Ottino A, Pianazola HM, Castelleto RH. Occult papillary thyroid carcinoma in autopsy in La Plata, Argentina. Cancer64, 547–551 (1989).
  • Bisi H, Fernandes VSO, Asato de Camargo RY et al. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies with special reference to the incidental carcinoma. Cancer64, 1888–1893 (1989).
  • Fink A, Tomlinson G, Freeman JL et al. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod. Pathol.9, 816–820 (1996).
  • Pelizzo MR, Piotto A, Rubello D et al. High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori76, 255–257 (1990).
  • Sakorafas GH, Stafyla V, Bramis C et al. Incidental parathyroidectomy during thyroid surgery: an underappreciated complication of thyroidectomy. World J. Surg.29, 1539–1543 (2005).
  • Sakorafas GH, Giotakis J, Stafyla V. Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat. Rev.31, 423–438 (2005).
  • Harach HR, Escalante DA, Williams ED et al. Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinol.108, 55–60 (1985).
  • Harach HR, Escalante DA, Day ES. Thyroid cancer and thyroiditis in Salta, Argentina: a 40-yr study in relation to iodine prophylaxis. Acta Endocrinol.13, 175–181 (2002).
  • Baudin E, Travagli JP, Ropers J et al. Microcarcinoma of the thyroid gland: the Gustave–Roussy Institute experience. Cancer83, 553–559 (1998).
  • Rodriguez JM, Moreno A, Parrilla P et al. Papillary thyroid microcarcinoma: clinical study and prognosis. Eur. J. Surg.163, 255–259 (1997).
  • Russo F, Barone Adesi TL, Arturi A et al. Clinico-pathological study of microcarcinoma of the thyroid. Minerva Chir.52, 891–900 (1997).
  • Satge D, Grob JC, Pusel J et al. Thyroid microcarcinoma with a fatal outcome and 34 other unusually aggressive cases reported in the literature. Arch. Anat. Cytol. Pathol.38, 143–151 (1990).
  • Hay ID, Grant CS, van Heerden JA et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery112, 1139–1146 (1992).
  • David JM, Ruaux C, Bachaud JM et al. Multiple localization and lymphatic involvement of papillary micro-carcinoma of the thyroid. Results of total thyroidectomy with bilateral lymph node excision. Apropos of 38 patients. Ann. Otolaryngol. Chir. Cervicofac.109, 183–187 (1992).
  • Chan JK. Papillary carcinoma of the thyroid: classical and variants. Histol. Histopathol.5, 241–257 (1990).
  • Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED. Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int. J. Surg. Pathol.11, 249–251 (2003).
  • Salvadori B, Del Bo R, Pilotti S et al. ‘Occult’ papillary carcinoma of the thyroid: a questionable entity. Eur. J. Cancer29A, 1817–1820 (1993).
  • Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br. J. Surg.83, 1674–1683 (1996).
  • Yokozawa T, Miyauchi A, Kuma K et al. Accurate and simple method of diagnosing thyroid nodules by the modified technique of ultrasound-guided fine needle aspiration biopsy. Thyroid5, 141–145 (1995).
  • Ito Y, Tomoda C, Uruno T et al. Papillary microcarcinoma of thyroid. How should it be treated? World J. Surg.28, 1150–1121 (2004).
  • Ito Y, Miyauchi A. A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Natl Clin. Pract. Endocrinol. Metab.3(3), 240–248 (2007).
  • Moley JF. Medullary thyroid carcinoma. In: Textbook of Endocrine Surgery. Clark OH, Duh QY (Eds). WB Saunders, Philadelphia, PA, USA 108–118 (1997).
  • Gilliland FD, Hunt WC, Morris DM et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973–1991. Cancer79, 564–573 (1997).
  • Hazard J, Hawk W, Crile D. Medullary (solid) carcinoma of the thyroid – a clinicopathologic entity. J. Clin. Endocrinol. Metab.19, 152–161 (1959).
  • Farndon JR, Leight GS, Dilley WG et al. Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br. J. Surg.73, 278–281 (1986).
  • Alsanea O, Clark OH. Familial thyroid cancer. Curr. Opin. Oncol.13, 44–51 (2001).
  • Chong GC, Beahrs OH, Sizemore GW et al. Medullary carcinoma of the thyroid gland. Cancer35, 695–704 (1975).
  • Clayman G, El-Baradie T. Medullary thyroid cancer. Otolaryngol. Clin. N. Am.36, 91–105 (2003).
  • Kikumori T, Evans D, Lee JE et al. Genetic abnormalities in multiple endocrine neoplasia type 2. In: Surgical Endocrinology. Doherty GM, Skogseid B (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA 531–540 (2001).
  • Raue F. Diagnosis of medullary thyroid cancer. In: Thyroid Cancer: Current Concepts in Diagnosis and Therapy. Biersack HJ, Grunwald F (Eds). Springer Verlag, Berlin, Germany 239–249 (2001).
  • Leboullex S, Baudin E, Travagli JP, Schlumberger M. Medullary thyroid carcinoma. Clin. Endocr.61, 299–310 (2004).
  • O’Riordain DS, O’Brien T, Crotty TB, Gharib H, Grant CS, van Heerden JA. Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery118, 936–942 (1995).
  • Van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann. Surg.212, 395–401 (1990).
  • O’Riordain DS, O’Brien T, Weaver AL et al. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery116, 1017–1023 (1994).
  • Hyer SL, Vini L, A’Hern R, Harmer C. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur. J. Surg. Oncol.26, 686–690 (2000).
  • Ramirez A, Escallon A. Surgical management of medullary thyroid carcinoma. Proceedings of: The 1st South Colombian Oncology Congress, Neiva, Huila, Colombia (2004).
  • Cohen MS, Moley JF. Surgical treatment of medullary thyroid carcinoma. J. Int. Med.253, 616–626 (2003).
  • Decker RA, Geiger JD, Cox CE, Mackovjak M, Sarkar M, Peacock ML. Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated? World J. Surg.20, 814–821 (1996).
  • Dionigi G, Bianchi V, Rovera F et al. Medullary thyroid carcinoma: surgical treatment advances. Expert Rev. Anticancer Ther.7(6), 877–885 (2007).
  • Miccoli P, Elisei R, Donatini G, Materazzi G, Berti P. Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene: initial experience. Surg. Endosc.21, 120–123 (2007).
  • Ain KB. Anaplastic thyroid carcinoma: a therapeutic challenge. Semin. Surg. Oncol.16, 64–69 (1999).
  • Bakiri F, Djemli FK, Mokrane LA, Djidel FK. The relative roles of endemic goiter and socio economic development status in the prognosis of thyroid carcinoma. Cancer82, 1146–1153 (1991).
  • Tan RK, Finley RK III, Driscoll D et al. Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck17, 41–47 (1995).
  • Ain KB. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid8, 715–726 (1998).
  • Tobler A, Maurer R, Hedinger CE. Undifferentiated thyroid tumors of diffuse small cell type. Histological and immunohistochemical evidence for their lymphomatous nature. Virchows Arch. A. Pathol. Anat. Histopathol.404, 117–126 (1984).
  • Holting T, Moller P, Tschahargane C, Meybier H, Buhr H, Herfarth C. Immunohistochemical reclassification of anaplastic carcinoma reveals small and giant cell lymphoma. World J. Surg.14, 291–295 (1990).
  • Spires JR, Schwartz MR, Miller RH. Anaplastic thyroid carcinoma: association with differentiated thyroid cancer. Arch. Otolaryngol. Head Neck Surg.114, 40–44 (1988).
  • DeMeter JG, De Jong SA, Lawrence AM, Paloyan E. Anaplastic thyroid carcinoma: risk factors and outcome. Surgery110, 956–963 (1991).
  • Schaefer CJ. Long term survival in anaplastic thyroid cancer. Md. Med J.37, 873–874 (1988).
  • McIver B, Hay ID, Giuffrida D et al. Anaplastic thyroid carcinoma: a 50 year experience at a single institution. Surgery130, 1028–1034 (2001).
  • Pasieka JL. Anaplastic thyroid cancer. Curr. Opin. Oncol.15, 78–83 (2003).
  • Venkatesh YSS, Ordonez NG, Schultz PN et al. Anaplastic carcinoma of the thyroid. Cancer66, 321–330 (1990).
  • Besic N, Auersperg M, Us-Krasovec M et al. Effect of primary treatment on survival in anaplastic thyroid carcinoma. Eur. J. Surg. Oncol.27, 260–264 (2001).
  • Lloyd RV. Thyroid. In: Endocrine Pathology. Lloyd RV (Ed.). Springer-Verlag, NY, USA, 37–70 (1990).
  • Sugitani I, Kasai N, Fujimota Y et al. Prognostic factor and therapeutic strategy for anaplastic carcinoma of the thyroid. World J. Surg.25, 617–622 (2001).
  • Kobayashi A, Asakawa H, Umeshita K et al. Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck18, 36–41 (1996).
  • Pacheco-Ojeda L, Martinez A, Alvarez M. Anaplastic thyroid carcinoma in Ecuador: analysis of prognostic factors. Int. Surg.86, 117–121 (2001).
  • Haigh P, Ituarte P, Wu JS et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer91, 2335–2342 (2001).
  • Sugino K, Ito K, Mimura T et al. The important role of operations in the management of anaplastic thyroid carcinoma. Surgery131, 245–248 (2002).
  • Junor EJ, Paul J, Redd NS. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur. J. Surg. Oncol.18, 83–88 (1992).
  • Haigh PI, Ituarte PH, Wu HS et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer91, 2335–2342 (2001).
  • Bergamaschi R, Becouarn G, Ronceray J, Arnaud JP. Morbidity of thyroid surgery. Am. J. Surg.176, 71–75 (1998).
  • Zarnegar R, Brunaud L, Clark OH. Prevention,evaluation and management of complications following thyroidectomy for thyroid carcinoma. Endocrinol. Metab. Clin. N. Am.32, 483–502 (2003).
  • Kennedy TL. Surgical complications of thyroidectomy. Operative techniques in otolaryngology-head and neck. Surgery14(2), 74–79 (2003).
  • Bellantone R et al. Is the identification of the external branch of the superior laryngeal nerve mandatory in thyroid operation? Results of a prospective randomized study. Surgery130, 1055–1059 (2001).
  • Jatzko GR, Lisborg PH, Muller MG et al. Recurrent nerve palsy after thyroid operation – principal nerve identification and a literature review. Surgery115, 139–144 (1994).
  • Al-Suliman NN, Ryttov NF, Quist N et al. Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. Eur. J. Surg.163, 13–20 (1997)
  • Kalky MI, Weber RS. Complications of surgery of the thyroid and parathyroid glands. Surg. Clin. N. Am.73, 307–320 (1993).
  • Sturniolo G, D’Alia C Tonante A et al. The recurrent laryngeal nerve related to thyroid surgery. Am. J. Surg.177, 485–188 (1999).
  • Mouret P. How I developed laparoscopic cholecystectomy. Ann. Acad. Med. Singapore25, 744–747 (1996).
  • Miccoli P, Berti P, Conte M et al. Minimally invasive surgery for small thyroid nodules: a preliminary report. J. Endocrinol. Invest.22, 849–851 (1999).
  • Miccoli P, Materazzi G. Minimally invasive, video-assited thyroidectomy (MIVAT). Surg. Clin. N. Am.84, 735–741 (2004).
  • Lombardi CP, Raffaelli M, Princi P, De Crea C, Bellantone R. Video-assisted thyroidectomy: report on the experience of a single center in more than four hundred cases. World J. Surg.30(5), 794–800 (2006).
  • Lombardi CP, Raffaelli M, Princi P, De Crea C, Bellantone R. Video-assisted thyroidectomy: report on a 7 year experience in Rome. Langenbecks Arch. Surg.391, 174–177 (2006).
  • Koops HS, Doting MH, de Vries J et al. Sentinel node biopsy as a surgical staging method for solid cancers. Radiother. Oncol.51(1), 1–7 (1999).
  • Wiseman SM, Loree TR, Hicks WL, Rigual NR. Sentinel lymph node biopsy in SCC of the head and neck: a major advance in staging the N0 neck. Ear Nose Throat J.81(3), 156–163 (2002).
  • Wiseman SM, Hicks WL, Chu QD, Rigual NR. Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg. Oncol.11, 137–142 (2002).
  • Park JW, Clark OH. Redifferentiation therapy for thyroid cancer. Surg. Clin. N. Am.84, 921–943 (2004).
  • Strate SM, Lee EL, Childers JH. Occult papillary carcinoma of the thyroid with distant metastases. Cancer54, 1093–1100 (1998).
  • Cady B. Primary carcinoma of the thyroid. Semin. Surg. Oncol.7, 81–86 (1991).
  • Tsuchiya A, Suzuki S, Kanno M et al. Prognostic factors associated with differentiated thyroid cancer. Surg. Today25, 778–782 (1995).
  • Yamamoto Y, Maeta T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer65, 1173–1179 (1990).
  • Appetecchia M, Scarcello G, Pucci E, Procaccini A. Outcome after treatment of papillary thyroid microcarcinoma. J. Exp. Clin. Cancer Res.21, 159–164 (2002).
  • Pellegriti G, Scollo C, Lumera G et al. Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J. Clin. Endocrinol. Metab.89, 3713–3720 (2004).
  • Santoro M, Papotti M, Chiappetta G et al. RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J. Clin. Endocrinol. Metab.87, 370–379 (2002).
  • Khoo ML, Freeman JL, Witterick IJ et al. Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease. Arch. Otolaryngol. Head Neck Surg.128, 253–257 (2002).
  • Sugitani I, Fujimoto Y. Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr. J.46, 209–216 (1999).
  • Brown DC, Gatter KC. Monoclonal antibody Ki-67, its use in histopathology. Histopathology17, 489 (1990)
  • Soda G, Antonaci A, Bosco D et al. Expression of bcl-2, c-erbB-2, p53, and p21 (wafl-cip1) protein in thyroid carcinomas. J. Exp. Clin. Cancer Res.18, 363–367 (1999).
  • Moley JF, Albinson C. Medullary thyroid carcinoma and the multiple endocrine neoplasia type 2 syndromes. In: Surgical Endocrinology. Doherty GM, Skogseid B (Eds). Lippincott Williams & Wilkins, Philadelphia, PA, USA 541–557 (2001).
  • Moley JF, De Benedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma. Recommendations for extent of node dissection. Ann. Surg.229, 880–888 (1999).
  • Scollo C, Baudin E, Travagli JP et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J. Clin. Endocrinol. Metab.88, 2070–2075 (2003).

Website

  • Schlumberger MJ. Anaplastic thyroid carcinoma. Orphanet encyclopedia, March 2004 www.orpha.net/data/patho/GB/uk-ATC.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.